Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank OCBC NISP Tbk. (NISP) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Bank OCBC NISP Tbk.Trade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank OCBC NISP Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Bank OCBC NISP Tbk. trades at Rp1,265 (market cap 29.08T, 6M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Bank OCBC NISP Tbk. is far larger — about 278.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

NISPSCPI
Market Cap
29.08T104.4B
Volume
6M
Lot
60K
Turnover
7.6B
Average Price
1,267.4
Value
7.6B
Indicative Equilibrium Price
1,265
Indicative Equilibrium Volume
5.23K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NISP
View details
SCPI
View details

About Bank OCBC NISP Tbk.

PT Bank OCBC NISP Tbk, formerly PT Bank NISP Tbk. Bank NISP was established in 1941 based on deed No. 6 dated April 4, 1941 of notary Theodoor Johan Indewey Gerlings, under the name NV. Nederlandsch Indische Spaar En Deposito Bank (NISP). On May 1995 the bank has raised a US$ 19 million loan, to finance its expanding export credits. On 22 September 2010, the Board of Commissioners and Directors of Bank OCBC NISP and PT Bank OCBC Indonesia (Bank OCBC Indonesia) approved the merger plan related to the merger of Bank OCBC Indonesia into Bank OCBC NISP where Bank OCBC NISP will become the surviving Bank. The effective date of the merger of the Bank with PT Bank OCBC Indonesia was determined on 1 January 2011 based on Notarial Deed No. 10 dated 9 November 2010 of Fathiah Helmi, SH., notary in Jakarta.

Read more on NISP

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI